Surotomycin is an investigational drug.
There have been 4 clinical trials for Surotomycin.
The most recent clinical trial was a Phase 3 trial, which was initiated on May 16th 2012.
The most common disease conditions in clinical trials are Diarrhea, Clostridium Infections, and [disabled in preview]. The leading clinical trial sponsors are Cubist Pharmaceuticals LLC, Merck Sharp & Dohme Corp., and [disabled in preview].